Avatar
Clave9porch

0 Following 0 Followers
1
Fraction by the heart failure and echocardiography associations of the European society of cardiology. Eur Heart J 2007, 28:2539?550. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977, 55:613?18.25. Pollentier B, Irons SL, Benedetto CM, Dibenedetto AM, Loton D, Seyler RD, et al: Examination of the six minute
1
Ulness of CTA or functional tests in screening asymptomatic diabetics [5,7,8,14]. No study to date has demonstrated additional value of CS and CTA when associated to clinical variables and classic risk scores, such as Framingham. This study aims to assess the additional benefit of CS and CTA, when added to clinical risk stratification schemes, to predict fatal and non fatal cardiovascular events i
1
Evaluated. Laboratorial tests included total cholesterol, triglycerides, high density lipoprotein cholesterol, low density lipoprotein cholesterol, hemoglobin A1c, serum creatinine, Creactive protein and microalbuminuria. Body mass index, GFR (MDRD formula) and Framingham risk score [17] were calculated. Hypertension and dyslipidemia were defined by a self-reported history or use of specific thera
1
Etabolic control marker (Table 6). The best cutoff for predicting cardiovascular events (86.6) identified 80 of patients who suffered a cardiovascular event and was associated with a risk of events 10.7 times higher over time. It was lower than the value commonly used to predict high risk of CAD in general population (400). A CS of 0, as a low risk marker, missed one patient with significant CAD
1
Etabolic control marker (Table 6). The best cutoff for predicting cardiovascular events (86.6) identified 80 of patients who suffered a cardiovascular event and was associated with a risk of events 10.7 times higher over time. It was lower than the value commonly used to predict high risk of CAD in general population (400). A CS of 0, as a low risk marker, missed one patient with significant CAD
1
Ause mortality, n ( ) Cardiovascular death Non-cardiovascular death CVEV and CS = 0, n ( ) CVEV and CS
1
Ause mortality, n ( ) Cardiovascular death Non-cardiovascular death CVEV and CS = 0, n ( ) CVEV and CS
1
To evaluate a potential association with the study endpoints. Cox regression (method Forward Conditional) was performed to identify the independent predictors of cardiovascular events over time. Treatment started after CT (revascularisation, antiplatelet agents, statins) and duration of diabetes were also regarded. The discriminatory power of cardiovascular events predictors was then evaluated thr